TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 167, Issue 1-2, 2005, Pages 170-174

  Kikuchi, Seiji ^a   Miyagishi, Ryuji ^b   Fukazawa, Toshiyuki ^b   Yabe, Ichiro ^a   Miyazaki, Yusei ^a   Sasaki, Hidenao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nishimaruyama Hospital   (Japan)

Author keywords

Japanese; Multiple sclerosis; Polymorphism; Susceptibility gene; TRAIL

Indexed keywords

HLA DR ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RACE DIFFERENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; APOPTOSIS REGULATORY PROTEINS; CONFIDENCE INTERVALS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24144453449     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.06.021     Document Type: Article

References (37)

1. O. Aktas, V. Osmanova, M. Beyer, S. Brocke, and F. Zipp Therapeutic modulation of the TRAIL system in autoimmune CNS inflammation J. Neuroimmunol. 118 2001 52 (Abstract)
2. C. Comi, M. Leone, S. Bonissoni, S. DeFranco, F. Bottarel, C. Mezzatesta, A. Chiocchetti, F. Perla, F. Monaco, and U. Dianzani Defective T cell Fas function in patients with multiple sclerosis Neurology 55 2000 921 927
3. A. Compston, and A. Coles Multiple sclerosis Lancet 359 2002 1221 1231
4. D.A. Dumat, G.C. Ebers, and A.D. Sadovnick Genetics of multiple sclerosis Lancet Neurol. 3 2004 104 110
5. G.C. Ebers, K. Kukay, D.E. Bulman, A.D. Sadovnick, G. Rice, C. Anderson, H. Armstrong, K. Cousin, R.B. Bell, W. Hader, D.W. Paty, S. Hashimoto, J. Oger, P. Duquette, S. Warren, T. Gray, P. O'Connor, A. Nath, A. Auty, L. Metz, G. Francis, J.E. Paulseth, T.J. Murray, W. Pryse-Phillips, and N. Risch A full genome search in multiple sclerosis Nat. Genet. 13 1996 472 476
6. T. Fukazawa, I. Yabe, S. Kikuchi, H. Sasaki, T. Hamada, K. Miyasaka, and K. Tashiro Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese J. Neurol. Sci. 166 1999 47 52
7. T. Fukazawa, K. Yamasaki, H. Ito, S. Kikuchi, M. Minohara, I. Horiuchi, E. Tsukishima, H. Sasaki, T. Hamada, Y. Nishimura, K. Tashiro, and J. Kira Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors Tissue Antigens 55 2000 199 205
8. T. Fukazawa, S. Kikuchi, M. Niino, I. Yabe, T. Hamada, and K. Tashiro Multiphasic demyelinating disorder with acute transverse myelitis in Japanese J. Neurol. 250 2003 624 626
9. T. Fukazawa, S. Kikuchi, M. Niino, I. Yabe, R. Miyagishi, H. Fukaura, T. Hamada, K. Tashiro, and H. Sasaki Attack-related severity. A key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders J. Neurol. Sci. 225 2004 71 78
10. A.C. Gomes, G. Jonsson, S. Mjomheim, T. Olsson, J. Hillert, and A. Grandien Upregulation of the apoptosis regulators cFLIP, CD95 and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis J. Neuroimmunol. 135 2003 126 134
11. H.L. Gray, E.L. Sorensen, J.S. Hunt, and C. Ober Three polymorphisms in the 3′ UTR of the TRAIL (TNF-related apoptosis-inducing ligand) gene Genes Immun. 2 2001 469 470
12. B. Hilliard, A. Wilmen, C. Seidel, T.S. Liu, R. Goke, and Y. Chen Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis J. Immunol. 166 2001 1314 1319
13. W.X. Huang, M.P. Huang, M.A. Gomes, and J. Hillert Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS Neurology 55 2000 928 934
14. I. Jeremias, I. Herr, T. Boehler, and K.M. Debatin TRAIL/Apo-2-ligand- induced apoptosis in human T cells Eur. J. Immunol. 28 1998 143 152
15. M. Jo, T.H. Kim, D.W. Seol, J.E. Esplen, K. Dorko, T.R. Billiar, and S.C. Strom Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nat. Med. 6 2000 564 567
16. S. Kikuchi, T. Fukazawa, M. Niino, I. Yabe, R. Miyagishi, T. Hamada, and K. Tashiro Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation J. Neuroimmunol. 128 2002 77 81
17. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
18. S.E. Lamhamedi-Cherradi, S.J. Zheng, K.A. Maguschak, J. Peschon, and Y.H. Chen Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice Nat. Immunol. 4 2003 255 260
19. S.M. Mariani, and P.H. Krammer Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells Eur. J. Immunol. 28 1998 1492 1498
20. M. Matysiak, A. Jurewicz, D. Jaskolski, and K. Selmaj TRAIL induces death of human oligodendrocytes isolated from adult brain Brain 125 2002 2469 2480
21. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, F.D. Lublin, H.F. McFarland, D.W. Paty, C.H. Polman, S.C. Reingold, M. Sandberg-Wollheim, W. Sibley, A. Thompson, S. van den Noort, B.Y. Weinshenker, and J.S. Wolinsky Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann. Neurol. 50 2001 121 127
22. R. Miyagishi, M. Niino, T. Fukazawa, I. Yabe, S. Kikuchi, and K. Tashiro C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis J. Neuroimmunol. 145 2003 135 138
23. M. Niino, T. Fukazawa, I. Yabe, S. Kikuchi, H. Sasaki, and K. Tashiro Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles J. Neurol. Sci. 177 2000 65 71
24. M. Niino, S. Kikuchi, T. Fukazawa, R. Miyagishi, I. Yabe, and K. Tashiro An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis BMC Neurol. 2 2002 8
25. M. Niino, S. Kikuchi, T. Fukazawa, I. Yabe, and K. Tashiro Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients J. Neuroimmunol. 136 2003 125 129
26. R. Nitsch, I. Bechmann, R.A. Deisz, D. Haas, T.N. Lehmann, U. Wendling, and F. Zipp Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) Lancet 356 2000 827 828
27. J.R. Oksenberg, S.E. Baranzini, L.F. Barcellos, and S.L. Hauser Multiple sclerosis: genomic rewards J. Neuroimmunol. 113 2001 171 184
28. J. Satoh, M. Nakanishi, F. Koike, S. Miyake, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Kanda, T. Fukazawa, and T. Yamamura Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis Neurobiol. Dis. 18 2004 537 550
29. M. Unoki, S. Furuta, Y. Onouchi, O. Watanabe, S. Doi, H. Fujiwara, A. Miyatake, K. Fujita, M. Tamari, and Y. Nakamura Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene Hum. Genet. 106 2000 440 446
30. T.J. Vyse, and J.A. Todd Genetic analysis of autoimmune disease Cell 85 1996 311 388
31. K.P. Wandinger, J.D. Lunemann, O. Wengert, J. Bellmann-Strobl, O. Aktas, A. Weber, E. Grundstrom, S. Ehrlich, K.D. Wernecke, H.D. Volk, and F. Zipp TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis Lancet 361 2003 2036 2043
32. Q. Wang, Y. Ji, X. Wang, and B.M. Evers Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene Biochem. Biophys. Res. Commun. 276 2000 466 471
33. A. Weber, K.P. Wandinger, W. Mueller, O. Aktas, O. Wengert, E. Grundstrom, S. Ehrlich, C. Windemuth, T. Kuhlmann, T. Wienker, W. Bruck, and F. Zipp Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis J. Neuroimmunol. 149 2004 195 201
34. B.G. Weinshenker Neuromyelitis optica: what it is and what it might be Lancet 361 2003 889 890
35. S.R. Wiley, K. Schooley, P.J. Smolak, W.S. Din, C.P. Huang, J.K. Nicholl, G.R. Sutherland, T.D. Smith, C. Rauch, and C.A. Smith Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
36. K. Yamasaki, I. Horiuchi, M. Minohara, Y. Kawano, Y. Ohyagi, T. Yamada, F. Mihara, H. Ito, Y. Nishimura, and J. Kira HLA-DPB1*0501 associated optico-spinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies Brain 122 1999 1689 1696
37. F. Zipp, P.H. Krammer, and M. Weller Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system Immunol. Today 20 1999 550 554